$237.27 2.5%
RMD Stock Price vs. AI Score
Data gathered: December 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Resmed (RMD)

Analysis generated May 1, 2024. Powered by Chat GPT.

Resmed is a global leader in the development, manufacturing, and marketing of medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. It primarily provides innovative products for sleep apnea treatment, including CPAP, Adaptive Servo-Ventilation, and other ventilatory devices. Also, Resmed has diversified into software solutions to streamline patient care and business workflows for healthcare professionals.

Read full AI stock Analysis

Stock Alerts - Resmed (RMD)

company logo Resmed | December 18
Price is down by -5.2% in the last 24h.
company logo Resmed | December 12
Insider Alert: Sandercock Brett is selling shares
company logo Resmed | December 9
Ro Khanna (member of U.S. congress) is buying shares
company logo Resmed | December 6
Insider Alert: FARRELL PETER C is selling shares

About Resmed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.


Resmed
Price $237.27
Target Price Sign up
Volume 3,050,000
Market Cap $34.8B
Year Range $172.67 - $255.53
Dividend Yield 0.92%
PE Ratio 30.66
Analyst Rating 50% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '241.25B759M717M311M395M2.200
Q2 '241.19B763M716M292M389M2.080
Q1 '241.21B742M693M300M382M2.130
Q4 '231.17B811M647M209M283M1.880
Q3 '231.11B734M600M219M298M1.640

Insider Transactions View All

Sandercock Brett filed to sell 93,864 shares at $244.2.
December 11 '24
FARRELL PETER C filed to sell 81,218 shares at $245.7.
December 5 '24
Rider Michael J filed to sell 9,113 shares at $248.9.
December 2 '24
Leong Justin filed to sell 21,718 shares at $243.1.
November 25 '24

Congress Trading View All

Politician Filing Date Type Size
Ro Khanna
Dec 6, 24 Buy $1K - $15K
Thomas Tuberville
Republican
Nov 16, 23 Buy $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Resmed?

The Market Cap of Resmed is $34.8B.

What is Resmed's PE Ratio?

As of today, Resmed's PE (Price to Earnings) ratio is 30.66.

What is the current stock price of Resmed?

Currently, the price of one share of Resmed stock is $237.27.

How can I analyze the RMD stock price chart for investment decisions?

The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.

Does RMD offer dividends to its shareholders?

Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.92%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Resmed?

Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.